Targeted exon skipping rescues ciliary protein composition defects in Joubert syndrome patient fibroblasts

Elisa Molinari, Simon A. Ramsbottom, Shalabh Srivastava, Philip Booth, Sumaya Alkanderi, Seamus M. McLafferty, Laura A. Devlin, Kathryn White, Meral Gunay-Aygun, Colin G. Miles, John A. Sayer

Research output: Contribution to journalArticlepeer-review

Abstract

Joubert syndrome (JBTS) is an incurable multisystem ciliopathy syndrome. The most commonly mutated gene in JBTS patients with a cerebello-retinal-renal phenotype is CEP290 (alias JBTS5). The encoded CEP290 protein localises to the proximal end of the primary cilium, in the transition zone, where it controls ciliary protein composition and signalling. We examined primary cilium structure and composition in fibroblast cells derived from homozygous and compound heterozygous JBTS5 patients with nonsense mutations in CEP290 and show that elongation of cilia, impaired ciliogenesis and ciliary composition defects are typical features in JBTS5 cells. Targeted skipping of the mutated exon c.5668 G > T using antisense oligonucleotide (ASO) therapy leads to restoration of CEP290 protein expression and functions at the transition zone in homozygous and compound heterozygous JBTS5 cells, allowing a rescue of both cilia morphology and ciliary composition. This study, by demonstrating that targeted exon skipping is able to rescue ciliary protein composition defects, provides functional evidence for the efficacy of this approach in the treatment of JBTS.

Original languageEnglish (US)
Article number10828
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Targeted exon skipping rescues ciliary protein composition defects in Joubert syndrome patient fibroblasts'. Together they form a unique fingerprint.

Cite this